| 2025 | | Selective STAT3 Allosteric Inhibitors HCB-5300 and HCB-5400 Alleviate Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
International journal of molecular sciences, 26(24). : 11981-11981, 2025 | 김지원, 백욱영, 서창희, 임선교 |
| 2025 | | Exploratory Pilot Study on the Serum Ceramide (16:0) to Sphingosine-1-Phosphate Ratio as a Potential Indicator of Lupus Nephritis and Disease Activity
International journal of molecular sciences, 26(24). : 11957-11957, 2025 | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2025 | | Three-Dimensional Bone Structural Analysis in Postmenopausal Patients With Rheumatoid Arthritis With and Without Bone Erosion
Journal of clinical densitometry, 28(4). : 101631-101631, 2025 | 김지원, 김현아, 서창희, 정윤석, 정주양, 최용준 |
| 2025 | | Association Between Cardiovascular Risk and Subclinical Atherosclerosis in Korean Female Patients with Systemic Lupus Erythematosus
Journal of clinical medicine, 14(20). : 7162-7162, 2025 | 김지원, 김현아, 박범희, 서창희, 정주양 |
| 2025 | | Real-world clinical response and efficacy of tacrolimus-based maintenance therapy for Korean patients with lupus nephritis
The Korean journal of internal medicine, 40(6). : 1052-1064, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2025 | | Characterising infusion/injection-related reactions in patients with rheumatoid arthritis treated with biologic agents
Clinical and experimental rheumatology, 43(9). : 1629-1637, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2025 | | Corrigendum to “A peptide derived from the core beta-sheet region region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models” [eBioMedicine 52 (2020) 102645]
EBioMedicine, 121. : 105953-105953, 2025 | 서창희 |
| 2025 | | Comprehensive analysis of patients with rheumatoid arthritis associated interstitial lung disease
The Korean journal of internal medicine, 40(5). : 845-855, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2025 | | Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study
Arthritis research & therapy, 27(1). : 113-113, 2025 | 서창희 |
| 2025 | | Difficult-to-treat rheumatoid arthritis among elderly patients from the KOBIO registry
European journal of internal medicine, 137. : 96-104, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2025 | | Evaluation of Inflammatory Scores as Diagnostic Markers for Polymyalgia Rheumatica
International journal of rheumatic diseases, 28(3). : e70153-e70153, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2025 | | Impact of disease-related indicators on pain measures in rheumatoid arthritis: a biopsychosocial perspective
Journal of rheumatic diseases, 32(1). : 38-47, 2025 | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | mHealth-Based Self-Management Program for Patients With Rheumatoid Arthritis: A Pilot Randomized Controlled Study
Nursing & health sciences, 26(4). : e13187-e13187, 2024 | 김지원, 부선주, 서창희 |
| 2024 | | Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus
International journal of molecular sciences, 25(16). : 8612-8612, 2024 | 강호철, 백욱영, 서창희, 정주양 |
| 2024 | | Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry
Clinical and experimental rheumatology, 42(9). : 1781-1791, 2024 | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation
International journal of molecular sciences, 25(12). : 6808-6808, 2024 | 김지연, 김지원, 김현아, 변혜은, 서창희, 정주양 |
| 2024 | | Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response
Frontiers in immunology, 15. : 1369385-1369385, 2024 | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2024 | | Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome
Clinical and experimental medicine, 24(1). : 133-133, 2024 | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2024 | | Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases
Postgraduate medical journal, 100(1183). : 334-341, 2024 | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia
International journal of rheumatic diseases, 27(1). : e14997-e14997, 2024 | 서창희 |
| 2024 | | Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis
The Korean journal of internal medicine, 39(1). : 172-183, 2024 | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus
European journal of clinical investigation, 54(1). : e14092-e14092, 2024 | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview
Expert opinion on drug metabolism & toxicology, 19(11). : 751-768, 2023 | 서창희 |
| 2023 | | Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Arthritis research & therapy, 25(1). : 174-174, 2023 | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study
Journal of rheumatic diseases, 30(3). : 198-203, 2023 | 서창희 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
Journal of Korean medical science, 38(32). : e247-e247, 2023 | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2023 | | Association between CCR2 and CCL2 expression and NET stimulation in adult-onset Still’s disease
Scientific reports, 13(1). : 12218-12218, 2023 | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2023 | | Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus
International journal of molecular sciences, 24(8). : 6927-6927, 2023 | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry
Clinical and experimental rheumatology, 41(5). : 1034-1041, 2023 | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | The transcription factor Mef2d regulates B:T synapse–dependent GC-TFH differentiation and IL-21–mediated humoral immunity
Science immunology, 8(81). : eadf2248-eadf2248, 2023 | 김지원, 서창희 |
| 2023 | | Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 37(2). : 247-257, 2023 | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
Rheumatology and therapy, 10(2). : 329-341, 2023 | 서창희 |
| 2022 | | Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
Journal of rheumatic diseases, 29(2). : 59-60, 2022 | 서창희 |
| 2022 | | Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 36(3). : 411-419, 2022 | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren’s syndrome
Clinical rheumatology, 41(10). : 3083-3093, 2022 | 강정현, 김지원, 김현아, 노진, 서창희, 안영실, 정주양, 한재호 |
| 2022 | | Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool
Journal of clinical medicine, 11(10). : 2830-2830, 2022 | 김지원, 김현아, 박성훈, 서창희, 정주양 |
| 2022 | | Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus
Journal of clinical medicine, 11(9). : 2406-2406, 2022 | 김현아, 서창희, 정주양 |
| 2022 | | Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus
Frontiers in medicine, 9. : 906475-906475, 2022 | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study
Clinical rheumatology, 41(2). : 367-375, 2022 | 김지원, 부선주, 서창희 |
| 2022 | | Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
The Korean journal of internal medicine, 37(5). : 1061-1069, 2022 | 서창희 |
| 2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus
Frontiers in immunology, 13. : 886209-886209, 2022 | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Publisher Correction: Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease
Scientific reports, 12(1). : 11885-11885, 2022 | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2022 | | Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease
Scientific reports, 12(1). : 10240-10240, 2022 | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2022 | | Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study
Annals of the rheumatic diseases, 81(9). : 1273-1280, 2022 | 서창희 |
| 2022 | | Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report
Medicine, 101(7). : E28908-E28908, 2022 | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature
Clinical rheumatology, 41(5). : 1583-1589, 2022 | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model
Journal of rheumatic diseases, 28(3). : 133-142, 2021 | 서창희 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83
Frontiers in immunology, 12. : 712312-712312, 2021 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2021 | | Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review
International journal of molecular sciences, 22(23). : 12903-12903, 2021 | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Toll‐like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus
International journal of molecular sciences, 22(23). : 12764-12764, 2021 | 서창희 |
